- Home
- DNTH vs IE Comparison
DNTH vs IE Comparison
Compare DNTH & IE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DNTH | IE |
|---|---|---|
| Founded | 2015 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Mining |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.0B |
| IPO Year | 2018 | 2022 |
Fundamental Metrics
Financial Performance| Metric | DNTH | IE |
|---|---|---|
| Price | $95.00 | $14.41 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 3 |
| Target Price | ★ $121.00 | $18.17 |
| AVG Volume (30 Days) | 844.8K | ★ 2.3M |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.79 |
| Revenue | $2,036,000.00 | ★ $3,244,000.00 |
| Revenue This Year | N/A | $44.79 |
| Revenue Next Year | $29.48 | $16.22 |
| P/E Ratio | ★ N/A | $17.06 |
| Revenue Growth | N/A | ★ 11.82 |
| 52 Week Low | $16.77 | $5.83 |
| 52 Week High | $92.27 | $21.55 |
Technical Indicators
Market Signals| Indicator | DNTH | IE |
|---|---|---|
| Relative Strength Index (RSI) | 76.73 | 62.09 |
| Support Level | $33.94 | $13.87 |
| Resistance Level | N/A | $17.44 |
| Average True Range (ATR) | 4.54 | 0.70 |
| MACD | 0.13 | 0.46 |
| Stochastic Oscillator | 97.35 | 99.48 |
Price Performance
Historical ComparisonAbout DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About IE Ivanhoe Electric Inc.
Ivanhoe Electric Inc is a United States-based d minerals exploration company with a focus on developing mines from mineral deposits principally located in the United States. The company has four business segments; Santa Cruz Project; critical metals; data processing services; and energy storage. It derives a majority of its revenue from Canada. The Santa Cruz Project and critical metals segments are focused on mineral project exploration and development. The data processing segment provides data analytics, geophysical modeling, and artificial intelligence services for the mineral, oil & gas, and water exploration industries. The energy storage segment develops, manufactures, and installs vanadium flow batteries for grid-scale energy storage.